Osage University Partners

oup.vc

VCMatch tracks Osage University Partners as an investor focused on Enterprise SaaS, Hardware, and Climate/Cleantech companies, Pre-Seed and Seed rounds, United States and Global markets, and $1m to $20m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$1m to $20m

Stages

Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage

Focus Areas

Enterprise SaaS, Hardware, Climate/Cleantech

Geography

United States and Global

Investment Thesis

OUP focuses on backing research-originated, deep-technology startups and helping them transition from laboratory discoveries to market-ready products. They invest across stages (“All stages, from pre-seed through crossover”) and provide both capital and hands-on support — leveraging a team of investors, scientists, operators and tech-transfer veterans to convert breakthrough research into commercial businesses.

Is Osage University Partners right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Osage University Partners is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Enterprise SaaS, Hardware, Climate/Cleantech, and Biotech, especially across United States and Global, with public check-size signals around $1m to $20m.

Focus statement

We invest in breakthrough startups emerging from the world’s leading research labs and innovation ecosystems, with sector focus on Tech (software, hardware, climate tech) and Life Science (therapeutics, medtech, diagnostics, research tools). They source deals through a global network of university partners and invest typically in the $1–20M range.

Value Add

Deep university network: "Partnerships with 150+ universities and research institutions across the US and abroad" and explicit emphasis on sourcing via university partners.
Domain expertise and team composition: team includes "former scientists, strategy consultants, and operators" and "tech transfer veterans" with long experience in academic startup formation.
Track record and outcomes: documented outcomes include "$800M under management", "150+ Portfolio Companies", "35+ IPOs", "9 approved medicines", and "11 approved medical products".
Hands-on commercialization support: emphasis on "turning technology into product" and experience "converting technology into market-winning products" (they describe having the "experience — and battle scars").
Long-term capital and partnership approach: "We are long-term partners to our companies, reserving meaningful capital for follow-on rounds and working side by side with founders."
Strong corporate and investor connections: they "plug our companies into our tight-knit community of Fortune 500 corporate leaders, strategic partners, and other founders" and proactively introduce companies to investors and hires.
Focused on academic founders and university ecosystems: consistent campus presence and interactions with TTOs, PIs, and students described as "unmatched expertise navigating the university entrepreneurial ecosystems."